Prescient Therapeutics targets rare T-cell cancer in new clinical trial, doses first patient

By Proactive Investors / May 28, 2025 / www.youtube.com / Article Link

Prescient Therapeutics Ltd CEO James McDonnell talked with Proactive about the initiation of a Phase 2A clinical trial for the ...

Recent News

Mining stocks not looking expensive versus returns

June 15, 2026 / www.canadianminingreport.com

Gold stocks gain even as metal declines

June 15, 2026 / www.canadianminingreport.com

Gold stocks plunge on metal and equities slump

June 08, 2026 / www.canadianminingreport.com

Market sees substantial chance of rate hike by end of year

June 08, 2026 / www.canadianminingreport.com

Minera Alamos expects major near-term rise in production

June 01, 2026 / www.canadianminingreport.com

See all >